Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial

Seymour, MT, Brown, SR, Middleton, G et al. (18 more authors) (2013) Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial. The Lancet Oncology, 14 (8). 749 - 759. ISSN 1470-2045

Abstract

Metadata

Authors/Creators:
  • Seymour, MT
  • Brown, SR
  • Middleton, G
  • Maughan, T
  • Richman, S
  • Gwyther, S
  • Lowe, C
  • Seligmann, JF
  • Wadsley, J
  • Maisey, N
  • Chau, I
  • Hill, M
  • Dawson, L
  • Falk, S
  • O'Callaghan, A
  • Benstead, K
  • Chambers, P
  • Oliver, A
  • Marshall, H
  • Napp, V
  • Quirke, P
Dates:
  • Published: July 2013
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Oncology and Clinical Research (Leeds) > Oncolocy/Cancer Research UK Clinical Centre (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 03 Nov 2014 11:15
Last Modified: 03 Nov 2016 02:31
Published Version: http://dx.doi.org/10.1016/S1470-2045(13)70163-3
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/S1470-2045(13)70163-3
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics